16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
This paid advertisement highlights Ventripoint Diagnostics' support for the Global Congenital Heart Disease Alliance, including the placement of four VMS+ imaging units. The article contextualizes congenital heart disease as a growing market opportunity, citing 16 million affected patients and a projected AI cardiology market growing to $14.2 billion by the 2030s.
Key figures
- Chd birth rate
- 2%
- Chd patients global
- 16 million
- Ai cardiology market 2026
- US$2.78 billion
- Ai cardiology market 2030s
- US$14.2 billion
- Echocardiography market 2030
- US$2.64 billion
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.